Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.83
-0.04 (-4.60%)
At close: Aug 19, 2025, 3:08 PM

Iterum Therapeutics Revenue

Iterum Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Iterum Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
9
Market Cap
36.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 -100.00%
Dec 31, 2019 37K -95.74%
Dec 31, 2018 869K +71.06%
Dec 31, 2017 508K +Infinity%
Dec 31, 2016 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.